Aptinyx Inc. Common Stock
APTX
APTX was delisted on the 18th of May, 2023.
57 hedge funds and large institutions have $59.5M invested in Aptinyx Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 24 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
15% less funds holding
Funds holding: 67 → 57 (-10)
25% less capital invested
Capital invested by funds: $79.3M → $59.5M (-$19.8M)
33% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$1.68M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$937K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$565K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$489K |
| 5 |
Two Sigma Investments
New York
|
+$326K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.27M |
| 2 |
BlackRock
New York
|
-$1.91M |
| 3 |
Morgan Stanley
New York
|
-$1.2M |
| 4 |
State Street
Boston,
Massachusetts
|
-$841K |
| 5 |
MOACM
Mutual of America Capital Management
New York
|
-$264K |
APTX Hedge Fund Activity: Q2 2019 in Review
57 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q2 2019, worth a combined $59.5M — down 25% from $79.3M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of APTX and 16 opened new positions — a net loss of 8 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Assenagon Asset Management, opening a new position worth an estimated $1.68M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $7.27M sold.
- 57 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q2 2019, down from 67 in Q1 2019.
- Funds reported $59.5M of Aptinyx Inc. Common Stock stock for Q2 2019, down 25% quarter-over-quarter.
- 16 funds opened new Aptinyx Inc. Common Stock positions in Q2 2019 and 24 closed out, a net change of -8 holders.
- The largest Aptinyx Inc. Common Stock buyer in Q2 2019 was Assenagon Asset Management, an estimated $1.68M added.
- The largest Aptinyx Inc. Common Stock seller in Q2 2019 was PFM Health Sciences, an estimated $7.27M sold.
Based on aggregated 13F filings for Q2 2019.